Home > Drug Search >
  • company_query: Aspen
  •   > 
Drug Filter
Category:
chemistry (17) biology (14)
Status:
Approved (11) Phase Ⅱ (13) Phase Ⅰ (7)
Clinical Stage:
Pending (4) Active (12) Discontinued (4)
Bio-Type:
Gene therapy (5) Cell therapy (1) Vaccine (4) Whole antibody (2)
Indication:
Acute lymphoblastic leukaemia (ALL) (2) Acute myeloid Leukemia (AML) (3) Anaesthetic (2) Arrhythmia (1) Breast cancer (3) promote weight gain after weight loss following extensive surgery (1) Chronic lymphocytic leukemia (CLL) (2) Chronic myeloid leukemia (CML ) (2) Chronic obstructive pulmonary disease (COPD) (1) Clostridium difficile infection (1) Respiratory-tract disorders (1) Depression (1) Herpes simplex virus (1) Pancreatitis (1) HBV infection (1) Insomnia (1) Malignancies (1) Melanoma (3) Neuropathic pain (1) Non small cell lung cancer (NSCLC) (1) Pancreatic cancer (1) Parkinson's disease (PD) (1) Prostate cancer (2) Solid tumours (1) Usher syndrome (1) Head and neck cancer (1) Hodgkin lymphoma (1) Colorectal cancer (1) Age-related macular degeneration (AMD) (1) Pain (1) Stroke (1) Brain injury (1) Diffuse large B cell lymphoma (1) Stargardt’s disease (1) Liver cancer (1)
Others:
Sort: Aprv. Year Alphabetical Prev Next
First Prev 1 2 Next Last GO
Recently Viewed Drugs:
Insert title here
Feed-Back To Top
ICP Permit 14047345| Beijing PSB Hai Dian Record 11010802017043 |(京)-经营性-2015-0023(互联网药品信息服务资格证书)
Insert title here
Feed-Back To Top